TB-500

TB-500 is a synthetic peptide research compound commonly associated with a fragment of thymosin beta-4 (Tβ4). It has attracted substantial interest in peptide research because of its relationship to the actin-binding region of thymosin beta-4 and its relevance to research involving cellular migration, tissue biology, angiogenesis, and cellular repair mechanisms.

The name TB-500 is used commercially for different related substances, so accurate product identification is particularly important. FDA documentation describes TB-500 as the N-acetylated heptapeptide N-acetyl-LKKTETQ, corresponding to residues 17–23 of thymosin beta-4.

TB-500 is supplied as a research compound for laboratory use only. It should not be represented as an approved medication or marketed for human or veterinary administration.

What Is TB-500?

TB-500 is commonly described as a synthetic fragment related to thymosin beta-4. Research has focused on the sequence LKKTETQ, a region within thymosin beta-4 associated with actin binding.

Thymosin beta-4 itself is a naturally occurring 43-amino-acid peptide involved in biological processes associated with actin regulation, cell movement, and tissue biology. Research into thymosin beta-4 has therefore provided an important scientific background for investigations involving TB-500 and related peptide fragments.

It is important, however, not to treat TB-500 and full-length thymosin beta-4 as interchangeable substances. Their structures are different, and product naming in the commercial market has not always been consistent.

TB-500 Research Overview

TB-500 has become a subject of research involving several areas of cellular and molecular biology.

Research interests include:

• Actin-related cellular processes
• Cell migration
• Tissue biology
• Angiogenesis research
• Cellular signalling
• Wound-healing mechanisms
• Regenerative biology
• Peptide pharmacology
• Molecular research
• Protein and peptide structure

These research areas should be understood as areas of scientific investigation rather than established therapeutic indications.

TB-500 and Thymosin Beta-4

Thymosin beta-4 is an endogenous peptide that plays an important role in actin regulation. The protein’s actin-related functions have been studied in connection with cell migration, tissue development, and repair processes.

TB-500 is generally associated with a shorter region of thymosin beta-4. Research has identified the LKKTETQ region as part of the actin-binding domain of the full-length peptide.

This distinction is important for researchers comparing different thymosin-related materials.

TB-500 Peptide Sequence

The TB-500 material described in current FDA documentation is the N-acetylated heptapeptide:

Ac-LKKTETQ

The sequence corresponds to amino acids 17–23 of thymosin beta-4.

Because the term “TB-500” has been used for different formulations, salts, and related materials, researchers should verify the exact molecular identity and analytical documentation of any product before using it in an experiment. FDA documentation specifically highlights inconsistent naming as a potential safety and identification concern.

Why Is TB-500 Studied?

Scientific interest in TB-500 is closely connected to research surrounding thymosin beta-4 and its biological role in actin regulation.

Actin is an important structural protein involved in cellular organisation and movement. Because cellular migration is central to many biological processes, researchers have investigated thymosin beta-4 and related peptide sequences in models involving cell movement, tissue biology, and repair.

Earlier research on thymosin beta-4 identified biological activity associated with cell migration and tissue repair, while more recent literature continues to evaluate the underlying mechanisms and translational potential.

TB-500 Research Applications

Cellular Migration Research

Cell migration is an important process in tissue biology and developmental research. TB-500-related sequences have been investigated in the context of cellular movement and actin-associated mechanisms.

Actin Biology

The relationship between TB-500 and the actin-binding region of thymosin beta-4 makes it relevant to research investigating cytoskeletal organisation and peptide-protein interactions.

Tissue Research

Thymosin beta-4 research has explored mechanisms associated with tissue development, repair, and remodelling. TB-500 is consequently of interest within broader tissue-biology research.

Angiogenesis Research

Thymosin beta-4 and related sequences have been investigated in experimental models involving vascular development and angiogenesis. These findings remain an area of scientific research and should not be presented as proof of a therapeutic effect for TB-500 in humans.

Peptide Pharmacology

TB-500 provides researchers with an opportunity to investigate the biological characteristics of a defined synthetic peptide fragment and compare its properties with full-length thymosin beta-4 and other peptide compounds.

TB-500 vs Thymosin Beta-4

TB-500 and thymosin beta-4 are related but not identical.

Thymosin beta-4 is a naturally occurring 43-amino-acid peptide.

TB-500 is commonly used to describe a synthetic fragment associated with the actin-binding region of thymosin beta-4.

Current FDA documentation identifies TB-500 as N-acetyl-LKKTETQ, while also noting that the commercial term TB-500 has been applied inconsistently to different related substances.

For research purposes, product identity should therefore be established from the actual analytical documentation rather than relying solely on the product name.

TB-500 Product Information

Product: TB-500
Related peptide: Thymosin beta-4
Commonly identified sequence: Ac-LKKTETQ
Peptide type: Synthetic thymosin beta-4 fragment
Research areas: Actin biology, cellular migration, tissue research, angiogenesis and peptide pharmacology
Intended use: Laboratory research only
Human use: Not for human use
Veterinary use: Not for veterinary use

Product-specific documentation should be reviewed for exact molecular identity, purity, batch information, analytical testing, storage requirements, and handling instructions.

Quality and Analytical Documentation

Accurate identification is especially important when working with TB-500 because regulatory documentation has highlighted inconsistent commercial naming of TB-500-related substances.

Where available, researchers should review:

• Certificate of Analysis (CoA)
• Batch or lot number
• Molecular identity
• Peptide sequence
• Purity information
• Analytical testing
• Molecular-weight information
• Storage documentation
• Handling information

A well-documented research compound allows laboratories to better establish what material was used in an experiment and improves reproducibility between batches.

Storage and Handling

TB-500 should be handled only by appropriately trained laboratory personnel using suitable laboratory procedures.

Storage conditions should be determined from the current product-specific documentation rather than generic online recommendations. Researchers should verify the applicable storage, handling, and laboratory safety requirements before beginning experimental work.

TB-500 Research and Current Evidence

TB-500 and related thymosin beta-4 research continue to attract scientific interest, but the evidence should be interpreted carefully.

A recent review of unapproved peptide therapies notes that human safety and efficacy data for several commonly marketed research peptides remain limited.

Research involving thymosin beta-4 has produced interesting findings in preclinical models, but evidence involving the specific TB-500 fragment should not automatically be treated as equivalent to evidence for full-length thymosin beta-4. Current FDA materials also identify important uncertainties concerning TB-500-related substances, including peptide impurities, aggregation, and limited human exposure information.

Frequently Asked Questions

What is TB-500?

TB-500 is a name commonly used for a synthetic peptide fragment related to thymosin beta-4. Current FDA documentation identifies TB-500 as the N-acetylated sequence Ac-LKKTETQ.

Is TB-500 the same as thymosin beta-4?

No. TB-500 is generally associated with a shorter synthetic fragment of thymosin beta-4, whereas thymosin beta-4 is a naturally occurring 43-amino-acid peptide.

What is the TB-500 sequence?

The TB-500 material described in current FDA documentation is Ac-LKKTETQ, corresponding to residues 17–23 of thymosin beta-4.

Why is TB-500 researched?

Research interest includes actin biology, cellular migration, tissue biology, angiogenesis, peptide pharmacology, and related cellular mechanisms.

Is TB-500 approved for human use?

TB-500 should not be represented as an FDA-approved medication. FDA materials state that important safety information regarding TB-500-related substances remains limited.

Is TB-500 used in sports?

TB-500 has been identified in anti-doping research and has been associated with prohibited use in sport. Researchers and athletes should consult the applicable current anti-doping rules for their sport and jurisdiction.

Why is product identification important for TB-500?

The term TB-500 has been used commercially for different related substances. FDA documentation specifically identifies inconsistent naming and differences between salts and derivatives as concerns for accurate identification.

Research Disclaimer

This page provides educational information about TB-500 for legitimate laboratory research purposes. It is not medical advice and does not establish TB-500 as a treatment, therapy, recovery agent, or performance-enhancing product.

TB-500 research material is not intended for human consumption, self-administration, or veterinary use. Researchers are responsible for following applicable laws, regulations, institutional requirements, laboratory safety procedures, and relevant sporting regulations.

TB-500 Research Peptide

TB-500 remains an interesting subject within peptide and cellular research because of its relationship to the actin-binding region of thymosin beta-4. Its potential relevance to cellular migration, tissue biology, cytoskeletal research, and peptide pharmacology makes accurate molecular identification particularly important.

For laboratories evaluating TB-500, the strongest foundation is clear product identity, batch-specific analytical documentation, appropriate storage information, and responsible research practices.